Jixing Pharmaceuticals

Bringing innovative science and medicines to underserved patients.

Headquarters: Shanghai
Founded: 2019
Business Model: B2B

Total Funding: $162.0M
Last Round: $162.0M Series DJan 2024

About

JIXING is a clinical-stage biopharmaceutical company headquartered in Shanghai committed to bringing innovative science and medicines to underserved patients. Backed by RTW Investments, LP, JIXING was founded in 2019 and partners with global biotechnology companies to develop and commercialize novel, innovative therapies.

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Create Free Account

Funding History

Sign up to view funding details

Create a free account to see full funding history, valuations, and investor participation.

Create Free Account

Investors

Sign up to view investors

Create a free account to see which investors have funded this company.

Create Free Account